J Palussière1, M Cazayus2, S Cousin3, M Cabart3, F Chomy3, V Catena2, X Buy2. 1. Imaging Department, Institut Bergonié, 229 cours de l'Argonne, 33076, Bordeaux, France. j.palussiere@bordeaux.unicancer.fr. 2. Imaging Department, Institut Bergonié, 229 cours de l'Argonne, 33076, Bordeaux, France. 3. Oncology Department, Institut Bergonié, Bordeaux, France.
Abstract
PURPOSE OF REVIEW: For patients with early stage non-small-cell lung cancer (NSCLC), thermal ablation (TA) has become in the least two decades an option of treatment used worldwide for patients with comorbidities who are not surgical candidates. Here, we review data published with different TA techniques: radiofrequency ablation (RFA), microwave ablation (MWA) and cryoablation. This paper reviews also the comparison that has been made between TA and stereotactic radiotherapy (SBRT). RECENT FINDINGS: A majority of retrospective studies, the absence of comparative studies, and the variety of techniques make difficult to get evident data. Nevertheless, these stand-alone techniques have demonstrated local efficacy for tumors less than 3 cm and good tolerance on fragile patients. Many recent reviews and database analyses show that outcomes after TA (mainly RFA and MWA) are comparable to SBRT in terms of survival rates. For patients who are unfit for surgery, TA has demonstrated interesting results for safety, benefits in overall survival, and acceptable local control.
PURPOSE OF REVIEW: For patients with early stage non-small-cell lung cancer (NSCLC), thermal ablation (TA) has become in the least two decades an option of treatment used worldwide for patients with comorbidities who are not surgical candidates. Here, we review data published with different TA techniques: radiofrequency ablation (RFA), microwave ablation (MWA) and cryoablation. This paper reviews also the comparison that has been made between TA and stereotactic radiotherapy (SBRT). RECENT FINDINGS: A majority of retrospective studies, the absence of comparative studies, and the variety of techniques make difficult to get evident data. Nevertheless, these stand-alone techniques have demonstrated local efficacy for tumors less than 3 cm and good tolerance on fragile patients. Many recent reviews and database analyses show that outcomes after TA (mainly RFA and MWA) are comparable to SBRT in terms of survival rates. For patients who are unfit for surgery, TA has demonstrated interesting results for safety, benefits in overall survival, and acceptable local control.
Entities:
Keywords:
Cryoablation; Early stage lung cancer; Microwave ablation; Non small cell lung cancer; Radiofrequency ablation; Thermal ablation
Authors: Muneeb Ahmed; Zhengjun Liu; Karim S Afzal; Dawn Weeks; S Melvyn Lobo; Jonathan B Kruskal; Robert E Lenkinski; S Nahum Goldberg Journal: Radiology Date: 2004-03 Impact factor: 11.105
Authors: Sarina Bains; Takashi Eguchi; Arne Warth; Yi-Chen Yeh; Jun-Ichi Nitadori; Kaitlin M Woo; Teh-Ying Chou; Hendrik Dienemann; Thomas Muley; Jun Nakajima; Aya Shinozaki-Ushiku; Yu-Chung Wu; Shaohua Lu; Kyuichi Kadota; David R Jones; William D Travis; Kay See Tan; Prasad S Adusumilli Journal: J Thorac Oncol Date: 2018-09-22 Impact factor: 15.609
Authors: Henry S Park; Frank C Detterbeck; David C Madoff; Brett C Bade; Ulas Kumbasar; Vincent J Mase; Andrew X Li; Justin D Blasberg; Gavitt A Woodard; Whitney S Brandt; Roy H Decker Journal: J Thorac Dis Date: 2022-06 Impact factor: 3.005